JP4383170B2 - ヒストン脱アセチル化酵素９ - Google Patents

ヒストン脱アセチル化酵素９ Download PDF

Info

Publication number
JP4383170B2
JP4383170B2 JP2003532668A JP2003532668A JP4383170B2 JP 4383170 B2 JP4383170 B2 JP 4383170B2 JP 2003532668 A JP2003532668 A JP 2003532668A JP 2003532668 A JP2003532668 A JP 2003532668A JP 4383170 B2 JP4383170 B2 JP 4383170B2
Authority
JP
Japan
Prior art keywords
hdac9
polypeptide
nucleic acid
activity
histone deacetylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003532668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503824A5 (https=
JP2005503824A (ja
Inventor
アーサー・ゼレント
ケヴィン・ペトリー
ファビアン・ギデス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2005503824A publication Critical patent/JP2005503824A/ja
Publication of JP2005503824A5 publication Critical patent/JP2005503824A5/ja
Application granted granted Critical
Publication of JP4383170B2 publication Critical patent/JP4383170B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2003532668A 2001-10-02 2002-10-02 ヒストン脱アセチル化酵素９ Expired - Fee Related JP4383170B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0123664.5A GB0123664D0 (en) 2001-10-02 2001-10-02 Histone deacetylase 9
PCT/GB2002/004455 WO2003029451A2 (en) 2001-10-02 2002-10-02 Histone deacetylase 9

Publications (3)

Publication Number Publication Date
JP2005503824A JP2005503824A (ja) 2005-02-10
JP2005503824A5 JP2005503824A5 (https=) 2006-01-05
JP4383170B2 true JP4383170B2 (ja) 2009-12-16

Family

ID=9923113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003532668A Expired - Fee Related JP4383170B2 (ja) 2001-10-02 2002-10-02 ヒストン脱アセチル化酵素９

Country Status (7)

Country Link
US (1) US7291492B2 (https=)
EP (1) EP1432792B1 (https=)
JP (1) JP4383170B2 (https=)
AT (1) ATE340257T1 (https=)
DE (1) DE60214867T2 (https=)
GB (1) GB0123664D0 (https=)
WO (1) WO2003029451A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002318364A1 (en) 2001-06-14 2003-01-02 Bristol-Myers Squibb Company Novel human histone deacetylases
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7381825B2 (en) 2003-03-17 2008-06-03 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0321694D0 (en) * 2003-09-16 2003-10-15 Ark Therapeutics Ltd Genes and their therapeutic use
EP1824831A2 (en) 2004-12-16 2007-08-29 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1896436A2 (en) 2005-05-11 2008-03-12 Takeda San Diego, Inc. Histone deacetylase inhibitors
EA200800321A1 (ru) 2005-07-14 2008-06-30 Такеда Сан Диего, Инк. Ингибиторы гистондеацетилазы
WO2008039461A2 (en) * 2006-09-27 2008-04-03 Thinsilicon Corp. Back contact device for photovoltaic cells and method of manufacturing a back contact
WO2008150769A2 (en) * 2007-05-31 2008-12-11 Thinsilicon Corporation Photovoltaic device and method of manufacturing photovoltaic devices
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
US8623853B2 (en) 2008-07-23 2014-01-07 The Brigham And Women's Hospital, Inc. Treatment of cancers characterized by chromosomal rearrangement of the NUT gene
KR101319674B1 (ko) * 2009-05-06 2013-10-17 씬실리콘 코포레이션 광기전 전지 및 반도체층 적층체에서의 광 포획성 향상 방법
WO2010144459A2 (en) * 2009-06-10 2010-12-16 Thinsilicon Corporation Photovoltaic modules and methods for manufacturing photovoltaic modules having tandem semiconductor layer stacks
US20110114156A1 (en) * 2009-06-10 2011-05-19 Thinsilicon Corporation Photovoltaic modules having a built-in bypass diode and methods for manufacturing photovoltaic modules having a built-in bypass diode
US11441672B2 (en) * 2019-10-29 2022-09-13 Lokar, Inc. Adjustable shift lever mount

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE320484T1 (de) 1999-12-08 2006-04-15 Axys Pharm Inc Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
WO2002036783A2 (en) 2000-10-31 2002-05-10 Bayer Aktiengesellschaft Regulation of human histone deacetylase
US20040077046A1 (en) 2000-12-20 2004-04-22 Dalia Cohen Histone deacetylase-related gene and protein
CA2465075A1 (en) * 2001-06-14 2002-12-27 Sloan-Kettering Institute For Cancer Research Hdac9 polypeptides and polynucleotides and uses thereof
AU2002318364A1 (en) * 2001-06-14 2003-01-02 Bristol-Myers Squibb Company Novel human histone deacetylases

Also Published As

Publication number Publication date
US20050130146A1 (en) 2005-06-16
EP1432792B1 (en) 2006-09-20
ATE340257T1 (de) 2006-10-15
WO2003029451A2 (en) 2003-04-10
DE60214867T2 (de) 2007-05-24
EP1432792A2 (en) 2004-06-30
DE60214867D1 (en) 2006-11-02
WO2003029451A3 (en) 2003-08-21
US7291492B2 (en) 2007-11-06
JP2005503824A (ja) 2005-02-10
GB0123664D0 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
JP4383170B2 (ja) ヒストン脱アセチル化酵素９
US8946390B2 (en) Cancer-associated antigen
JP2008113660A (ja) ヒストンデアセチラーゼ関連遺伝子およびタンパク質
JP2004526444A (ja) Ｓｔｅａｐ関連タンパク質
US20050170500A1 (en) Methods for identifying risk of melanoma and treatments thereof
JP2011254830A (ja) 結腸癌に関するポリヌクレオチド
Pizzo et al. Ribonucleases with angiogenic and bactericidal activities from the Atlantic salmon
CA2331769A1 (en) Prostate cancer-associated genes
US20030143712A1 (en) Histone deacetylase and methods of use thereof
US20050277118A1 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
JPH0193537A (ja) アンギオゲニンの抑制剤
AU777096B2 (en) Differentially expressed genes associated with Her-2/neu overexpression
JPH07149654A (ja) アンギオゲニンの抑制剤
JP2002523045A (ja) ヒトｒｎａ関連タンパク質
JP4232423B2 (ja) 新規ユビキチン特異プロテアーゼ
US20040248259A1 (en) VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor
JP2003189884A (ja) 新規ユビキチン特異プロテアーゼ
KR20020013477A (ko) 염색체 17ｐ 연관된 전립선암 감수성 유전자
JP2005506838A (ja) ヒトスルファターゼファミリーメンバーｍｉｄ９００２およびその使用
JP2003523202A (ja) 単離ヒトホスファターゼタンパク質、ヒトホスファターゼタンパク質をコードする核酸分子及びその使用方法
WO2008033990A2 (en) Compositions and methods for modulating the notch signal transduction pathway

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050927

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080701

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080918

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090511

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090518

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090731

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090825

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090918

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121002

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131002

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees